bluebird bio News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.09.24	Bluebird Bio To Reduce Approx. 25% Of Its Workforce - Quick Facts (RTTNews)
29.05.24	Bluebird Bio Appoints Sterling As CFO (RTTNews)
18.03.24	Bluebird Bio Secures Debt Financing - Quick Facts (RTTNews)
11.03.24	Bluebird Bio Enters Medicaid Outcomes-based Agreement For LYFGENIA - Quick Facts (RTTNews)
20.12.23	Bluebird Bio Prices Public Offering Of 83.33 Mln Shares At $1.50/shr; Stock Plunges (RTTNews)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
07.11.23	Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates (RTTNews)
16.08.23	Bluebird Bio: No FDA Advisory Committee Meeting Scheduled For Lovo-cel Gene Therapy (RTTNews)
21.06.23	Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review (RTTNews)
29.03.23	Bluebird Bio Plunges On Lower Quarterly Revenue Below Estimates (RTTNews)
19.01.23	Bluebird Bio Prices Public Offering Of 20 Mln Shares At $6.00/shr (RTTNews)
18.01.23	Bluebird Bio Commences Public Offering Of Common Stock - Quick Facts (RTTNews)
06.01.23	Bluebird Bio Announces Sale Of Second Rare Pediatric Disease Priority Review Voucher For $95 Mln (RTTNews)
19.12.22	FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies (RTTNews)
19.09.22	Pre-market Movers: BCAN, REUN, FOXO, ETNB, INO… (RTTNews)
17.09.22	Bluebird Bio Gets Accelerated Approval For SKYSONA Gene Therapy For Cerebral Adrenoleukodystrophy (RTTNews)
12.09.22	Bluebird Bio Chief Strategy And Financial Officer Jason Cole To Resign (RTTNews)
27.08.22	Biotech Stocks Facing FDA Decision In September (RTTNews)
18.08.22	Pre-market Movers: BRSH, CDAK, BWV, WOLF, AVGR… (RTTNews)
18.08.22	FDA Approves Bluebird Bio's Gene Therapy For Rare Blood Disease (RTTNews)
13.06.22	Pre-market Movers: BLUE, MSTR, VALN, RDBX, DBVT… (RTTNews)
11.06.22	FDA Panel Endorses Bluebird Bio's Beti-cel Gene Therapy For Rare Blood Disease (RTTNews)
10.06.22	FDA Panel To Scrutinize Bluebird Bio's Beti-cel Gene Therapy For Beta-thalassemia Today (RTTNews)
10.06.22	FDA Panel Endorses Bluebird Bio's Eli-cel Gene Therapy For Rare Neurodegenerative Disease (RTTNews)
09.06.22	Bluebird Bio Stock Trading Halted Today And Tomorrow By Nasdaq (RTTNews)
27.05.22	Biotech Stocks Facing FDA Decision In June 2022 (RTTNews)
05.05.22	Pre-market Movers: AUST, HYMC, BLUE, CASA, AMWL… (RTTNews)
05.04.22	Bluebird To Cut Workforce By About 30% (RTTNews)
28.02.22	Biotech Stocks Facing FDA Decision In March 2022 (RTTNews)
18.01.22	Bluebird Bio : FDA PDUFA Goal Dates For Lentiviral Vector Gene Therapies Extended By Three Months (RTTNews)
20.12.21	Why Bluebird Bio Stock Falling In Pre-market? (RTTNews)
13.12.21	Pre-market Movers: ARNA, FHTX, PTPI, BDR, BLUE… (RTTNews)
05.11.21	Pre-market Movers: RWLK, OTRK, EVAX, NRXP, PTON… (RTTNews)
08.09.21	Bluebird Bio Secures $75 Mln In Private Placement Equity Financing (RTTNews)
24.07.21	BLUEBIRD BIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE (PR Newswire)
07.06.21	Bluebird Bio: FDA Lifts Clinical Hold On Sickle Cell Disease And ?-Thalassemia Studies - Quick Facts (RTTNews)
29.03.21	FDA Approves First Cell-Based Gene Therapy For Adult Multiple Myeloma Patients (RTTNews)
24.02.21	BLUE To Face FDA Next Month, SNSS Catches Eyes, ADVM On Watch (RTTNews)
17.02.21	BLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August (RTTNews)
11.01.21	Bluebird Bio's Board Approves Plan To Separate Into Two Companies - Quick Facts (RTTNews)
05.11.20	Bluebird Bio Q3 Loss Narrows; Adjusts LentiGlobin BLA Submission Timing To Late 2022 (RTTNews)
02.10.20	Bluebird Bio: European Medicines Agency To Review Eli-cel MAA Under Accelerated Assessment (RTTNews)
30.07.20	ALEC Falls Despite Promising Results, DNLI Makes Progress In COVID-19 Trial, EARS, ONTX On Watch (RTTNews)
14.05.20	FDA Snubs BMY And BLUE, Stocks That Moved On ASCO Abstracts (ARVN, CTMX, MGNX) (RTTNews)
19.02.20	Stock Alert: Bluebird Bio Stock Down 8% On Mixed Q4 Results (RTTNews)
01.11.19	BGNE Soars, DRNA Hits New High On Roche Deal, FDA Heeds REPH's Request (RTTNews)
14.09.19	Week Ahead In Pharmaceuticals: 7 Stocks To Watch (AIMT, LXRX, TXG…) (RTTNews)
10.01.19	10 Gene Therapy Companies Unignorable In 2019 (RTTNews)
06.08.18	Regeneron, Bluebird Bio Announce Collaboration - Quick Facts (RTTNews)
27.05.18	An Ear To The Pharma: 12 Stocks To Watch (AIMT, TXMD, MDGL…) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu bluebird bio Inc

Aktien Top/Flop

Meistgelesene Nachrichten